We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
+15.25%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$126M
AUM Growth
+$10.2M
(+8.8%)
Cap. Flow
-$2.86M
Cap. Flow
% of AUM
-2.27%
Top 10 Holdings %
Top 10 Hldgs %
41.21%
Holding
111
New
16
Increased
15
Reduced
24
Closed
15
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$2.72M |
| 2 |
Spyre Therapeutics
SYRE
|
+$2.69M |
| 3 |
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
|
+$2.28M |
| 4 |
Tandem Diabetes Care
TNDM
|
+$2.22M |
| 5 |
LOXO
Loxo Oncology, Inc
LOXO
|
+$1.57M |
Top Sells
| 1 |
AbbVie
ABBV
|
+$2.45M |
| 2 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
+$2.19M |
| 3 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$2M |
| 4 |
MASI
Masimo
MASI
|
+$1.7M |
| 5 |
CYAD
Celyad Oncology SA American Depositary Shares
CYAD
|
+$1.32M |
Sector Composition
| 1 | Healthcare | 71.02% |
| 2 | Financials | 0% |
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML